Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Restore Medical gets VC funds for snore therapy:

This article was originally published in Clinica

Executive Summary

Restore Medical, of St Paul, Minnesota, has raised $26.5m in a series C financing led by Bessemer Venture Partners. The company said the proceeds would help it continue commercialisation of the Pillar system, a minimally invasive treatment for snoring. It also plans to expand its business in sleep and breathing technology. The Pillar system obtained FDA approval to treat snoring in December 2002, and a 510(k) application has been submitted for its use in treating patients with obstructive sleep apnoea. It is a small woven polyester device that is implanted under local anaesthesia in a patient's soft palate.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts